ConverGene's Grant

ConverGene raised a round of funding on July 23, 2013. Investors include Maryland Technology Development Corporation.

ConverGene has discovered and developed a propriety library of small molecules that have profound effects on the MYC gene, a critical oncogene that controls progression of cancer. From this compound l…

Articles about ConverGene's Grant: